Follow
Jeremiah Wala
Jeremiah Wala
Fellow, Hematology/Oncology, DFCI/MGH
Verified email at dfci.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Pan-cancer patterns of somatic copy number alteration
TI Zack, SE Schumacher, SL Carter, AD Cherniack, G Saksena, B Tabak, ...
Nature genetics 45 (10), 1134-1140, 2013
18912013
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1657*2020
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ...
Nature medicine 24 (5), 679-690, 2018
15342018
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ...
Nature genetics 48 (6), 607-616, 2016
11082016
Patterns of somatic structural variation in human cancer genomes
Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ...
Nature 578 (7793), 112-121, 2020
6892020
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ...
Nature genetics 52 (3), 331-341, 2020
5372020
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
4992020
SvABA: genome-wide detection of structural variants and indels by local assembly
JA Wala, P Bandopadhayay, NF Greenwald, R O'Rourke, T Sharpe, ...
Genome research 28 (4), 581-591, 2018
3292018
Structural alterations driving castration-resistant prostate cancer revealed by linked-read genome sequencing
SR Viswanathan, G Ha, AM Hoff, JA Wala, J Carrot-Zhang, CW Whelan, ...
Cell 174 (2), 433-447. e19, 2018
3182018
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ...
Nature genetics 52 (3), 306-319, 2020
3152020
A robust benchmark for detection of germline large deletions and insertions
JM Zook, NF Hansen, ND Olson, L Chapman, JC Mullikin, C Xiao, ...
Nature biotechnology 38 (11), 1347-1355, 2020
2692020
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
P Bandopadhayay, LA Ramkissoon, P Jain, G Bergthold, J Wala, R Zeid, ...
Nature genetics 48 (3), 273-282, 2016
2672016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ...
Nature genetics 48 (8), 848-855, 2016
1962016
Genomic landscape of high-grade meningiomas
WL Bi, NF Greenwald, M Abedalthagafi, J Wala, WJ Gibson, PK Agarwalla, ...
NPJ genomic medicine 2 (1), 15, 2017
1842017
Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs
K Hadi, X Yao, JM Behr, A Deshpande, C Xanthopoulakis, H Tian, ...
Cell 183 (1), 197-210. e32, 2020
1662020
Multicriteria VMAT optimization
D Craft, D McQuaid, J Wala, W Chen, E Salari, T Bortfeld
Medical physics 39 (2), 686-696, 2012
1452012
Oncogenic RIT1 mutations in lung adenocarcinoma
AH Berger, M Imielinski, F Duke, J Wala, N Kaplan, GX Shi, DA Andres, ...
Oncogene 33 (35), 4418-4423, 2014
912014
The whole-genome panorama of cancer drivers
R Sabarinathan, O Pich, I Martincorena, C Rubio-Perez, M Juul, J Wala, ...
BioRxiv, 190330, 2017
542017
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
AL Hong, YY Tseng, JA Wala, WJ Kim, BD Kynnap, MB Doshi, G Kugener, ...
Elife 8, e44161, 2019
402019
Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning
J Wala, D Craft, J Paly, A Zietman, J Efstathiou
Medical Dosimetry 38 (3), 298-303, 2013
382013
The system can't perform the operation now. Try again later.
Articles 1–20